Raymond James Financial Inc Neogenomics Inc Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 49,769 shares of NEO stock, worth $288,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,769
Previous 50,906
2.23%
Holding current value
$288,660
Previous $838,000
43.68%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
286Shares Held
126MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$114 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$82.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$39 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$35 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$33.3 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $730M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...